Bowel Obstruction Market

Market Overview:

The 7 major bowel obstruction markets reached a value of US$ 16.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 27.4 Billion by 2034, exhibiting a growth rate (CAGR) of 4.9% during 2024-2034.

The bowel obstruction market has been comprehensively analyzed in IMARC's new report titled "Bowel Obstruction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Bowel obstruction refers to a condition in which there is a partial or complete blockage in the normal flow of digested food, fluids, and gas through the intestines. It can occur in either the small intestine or the large intestine, leading to a range of distressing symptoms. Common indications of the ailment include severe abdominal pain and cramping, bloating, nausea, vomiting, constipation, and the inability to pass gas or have a bowel movement. The severity of symptoms can differ based on the degree and location of the obstruction. The diagnosis of bowel obstruction typically involves a combination of medical history assessment, physical examination, and imaging studies. Doctors may use numerous techniques, such as X-rays, CT scans, ultrasounds, etc., to visualize the intestines and identify the blockage. Blood tests might also be conducted to check for signs of infection or dehydration. Prompt diagnosis and intervention are crucial to preventing potential complications, such as bowel perforation or tissue damage.

The escalating instances of intestinal blockages, attributed to the physical or functional barrier, that can hinder the normal flow of contents through the digestive tract are primarily driving the bowel obstruction market. In addition to this, the rising adoption of effective interventions, including surgery, nasogastric decompression, intravenous fluids, etc., which are aimed at alleviating the condition and averting further complications in individuals suffering from the disorder, is creating a positive outlook for the market. Moreover, the widespread utilization of advanced imaging techniques and diagnostic tools, as they facilitate accurate and timely identification of the obstruction's location and nature, is also augmenting the market growth. Apart from this, the increasing application of non-invasive methods, such as colonic stents and prokinetic agents, to aid in promoting bowel movement and alleviating obstruction is acting as another significant growth-inducing factor. Additionally, the emerging popularity of personalized medicine involving tailoring treatment approaches based on individual patient characteristics and the underlying causes of the disease, is also propelling the market growth. Furthermore, the inflating utilization of minimally invasive procedures like endoscopic techniques and laparoscopic surgeries, which enable precise removal of obstructions while minimizing post-operative complications, is expected to drive the bowel obstruction market during the forecast period.

IMARC Group's new report provides an exhaustive analysis of the bowel obstruction market in the United States, EU4 (Germany, Spain, Italy, and France), United Kingdom, and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report, the United States has the largest patient pool for bowel obstruction and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario, unmet medical needs, etc., have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the bowel obstruction market in any manner.

Key Highlights:

• Bowel obstruction can be mechanical or functional, affecting either the small or large bowel.
• The small bowel is involved in approximately 80% of mechanical bowel obstructions.
• Ischemia, which complicates up to 42% of bowel obstructions, considerably raises the risk of death from obstruction.
• The condition is a critical problem that surgeons face every day, with a mortality rate of roughly 10% to 15%.
• After abdominal surgery, the risk of small bowel obstruction from any cause is 9%.

Time Period of the Study

• Base Year: 2023
• Historical Period: 2018-2023
• Market Forecast: 2024-2034

   

Countries Covered

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
   

Analysis Covered Across Each Country

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the bowel obstruction market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the bowel obstruction market
• Reimbursement scenario in the market
• In-market and pipeline drugs

Competitive Landscape:

This report also provides a detailed analysis of the current bowel obstruction marketed drugs and late-stage pipeline drugs.

In-Market Drugs

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
   

Late-Stage Pipeline Drugs

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance

Key Questions Answered in this Report:

Market Insights

• How has the bowel obstruction market performed so far and how will it perform in the coming years?
• What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?
• What was the country-wise size of the bowel obstruction market across the seven major markets in 2023 and what will it look like in 2034?
• What is the growth rate of the bowel obstruction market across the seven major markets and what will be the expected growth over the next ten years?
• What are the key unmet needs in the market?
   

Epidemiology Insights

• What is the number of prevalent cases (2018-2034) of bowel obstruction across the seven major markets?
• What is the number of prevalent cases (2018-2034) of bowel obstruction by age across the seven major markets?
• What is the number of prevalent cases (2018-2034) of bowel obstruction by gender across the seven major markets?
• How many patients are diagnosed (2018-2034) with bowel obstruction across the seven major markets?
• What is the size of the bowel obstruction patient pool (2018-2023) across the seven major markets?
• What would be the forecasted patient pool (2024-2034) across the seven major markets?
• What are the key factors driving the epidemiological trend of bowel obstruction?
• What will be the growth rate of patients across the seven major markets?
   

Bowel Obstruction: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

• What are the current marketed drugs and what are their market performance?
• What are the key pipeline drugs and how are they expected to perform in the coming years?
• How safe are the current marketed drugs and what are their efficacies?
• How safe are the late-stage pipeline drugs and what are their efficacies?
• What are the current treatment guidelines for bowel obstruction drugs across the seven major markets?
• Who are the key companies in the market and what are their market shares?
• What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the bowel obstruction market?
• What are the key regulatory events related to the bowel obstruction market?
• What is the structure of clinical trial landscape by status related to the bowel obstruction market?
• What is the structure of clinical trial landscape by phase related to the bowel obstruction market?
• What is the structure of clinical trial landscape by route of administration related to the bowel obstruction market?